Pharmacology, Toxicology and Pharmaceutical Science
Rosuvastatin
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
80%
Atorvastatin
74%
Drug-Drug Interaction
61%
Hydroxychloroquine
58%
Lactone
58%
SLCO1B1
58%
Ticagrelor
58%
ABCG2
58%
Solanidine
58%
Cytochrome P450
54%
ABCG2
49%
Ticagrelor
46%
Effusion
45%
Pitavastatin
45%
Acid
45%
Fluindostatin
41%
Enzyme
36%
Statin (Protein)
35%
Simvastatin
35%
CYP3A4
35%
Multidrug Resistance Associated Protein 3
32%
CYP2D6
32%
P-Glycoprotein
25%
Rhabdomyolysis
23%
CYP2C8
22%
Pravastatin
22%
Oxidoreductase
19%
HMG-CoA
19%
Pharmacodynamics
19%
Drug Interaction
16%
Pharmacokinetics
13%
Drug
13%
Multidrug Resistance Associated Protein 4
12%
Allopurinol
12%
Polypeptide
11%
CYP2C9
9%
Base
9%
Emergency
9%
Placebo
8%
Glycodeoxycholic Acid
8%
Glycochenodeoxycholic Acid
8%
Glucuronosyltransferase
8%
Clopidogrel
8%
Potato
7%
Multidrug Resistance-Associated Protein 2
6%
Lipid
6%
Cytochrome P450 3A Inhibitor
6%
Cytochrome P450 2D6 Inhibitor
6%
Deethylchloroquine
6%
Biochemistry, Genetics and Molecular Biology
Statin
58%
ABCG2
58%
Pharmacogenetics
58%
SLCO1B1
58%
CYP2D6
58%
Atorvastatin
45%
Rosuvastatin
32%
Multidrug Resistance Associated Protein
32%
Fluvastatin
32%
P-Glycoprotein
25%
Pitavastatin
25%
Intestine Absorption
19%
Biliary Excretion
12%
Pravastatin
12%
Clearance
12%
Genotyping
10%
Metabolic Pathway
9%
Drug Interaction
7%
Simvastatin
6%
Hepatocyte
6%
Membrane Vesicle
6%
Transporter Protein
6%
Tissue Level
6%
Protein Expression Level
6%
Liquid
6%
Mass Spectrometry
6%
Allele
5%
Creatine Kinase
5%
Neuroscience
UGT2B7
58%
Glucuronidation
58%
Hydroxychloroquine
58%
Cytochrome P450 2D6
38%
Cytochrome P450 3A4
25%
Cytochrome P450 2C8
22%
Cytochrome P450
22%
Microsome
19%
Enzymes
12%
Cytochrome P450 3A
9%
Glucuronosyltransferase
8%
In Vitro
6%
